Substance P Regulation in Epilepsy-Reference-Cited by-同舟云学术

Substance P Regulation in Epilepsy

Published:2017-12-14 Issue:1 Volume:16 Page:
ISSN:1570-159X
Container-title:Current Neuropharmacology
language:en
Short-container-title:CN

Author:

Chi Guangfan¹,Huang Zhehao²,Li Xianglan²,Zhang Kun³,Li Guangquan³

Affiliation:

1. The Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun 130021, Jilin, China

2. China-Japan Union Hospital of Jilin University, Changchun 130031, Jilin, China

3. Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, China

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology,General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aprepitant’s roles in abating seizures, behavioral, and cognitive deficits in mice model of epilepsy;Epilepsy & Behavior;2024-10

2. Brain–computer interfaces: the innovative key to unlocking neurological conditions;International Journal of Surgery;2024-08-14

3. Bibliometric analysis of research in epilepsy and comorbid depression from 2014 to 2023;World Journal of Psychiatry;2024-06-19

4. Substance P promotes the progression of bronchial asthma through activating the PI3K/AKT/NF-κB pathway mediated cellular inflammation and pyroptotic cell death in bronchial epithelial cells;Cell Cycle;2022-06-26

5. Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders;International Journal of Molecular Sciences;2022-02-26